The work of @CivicaRx@MgVantrieste and @costplusdrugs@mcuban will have huge, positive, public health implications. -->> Civica Rx begins selling its first outpatient generic drug as it tries to overhaul the... https://t.co/3vti2HQg1B via @statnews
Exciting development from @CivicaRx at same time that @costplusdrugs is rolling out HUGE price differentials.
Disruption before our eyes?!?
https://t.co/f2wTa0BThQ
When asked, "what's your secret sauce?" @CivicaRx's @coukell replied, "we always think of the patient first." A roundtable today on US Manufacturing & Supply Sustainability w/ US Sen @MarkWarner (VA), VA and Petersburg teams, & partners @PhlowUSA, @AmpacFineChem, @MedsforAll
@alexisohanian@CivicaRx Thanks Alexis. CivicaRx is democratizing insulin, and will make it available to everyone at a fair, low price! CivicaRx = You Deserve to Live Pharmaceuticals. We will always act in the best interests of patients. #Civicarx https://t.co/bK9DSQfcn4
Big development in the Diabetes world today! Our partner, @Civicarx announced plans to manufacture and distribute three insulins that will be available at a significantly lower price than insulins currently on the market. We’re excited to follow them on their journey!
The story by @hjcarlsonk gives important details. The 3 insulins that @CivicaRx will manufacture are modern analog insulins: glargine, lispro and aspart, which will be interchangeable with Lantus, Humalog and Novolog, respectively. This is huge.
https://t.co/y4XHBlOoPY
Important to note that the prices quoted in this article for @civicarx#affordableinsulin are the maximum price to a any consumer at the pharmacy counter, not @civicarx selling price.
With 1 in 4 Americans skipping doses or taking less insulin than prescribed due to the unaffordability of the prices set by today’s insulin manufacturers, @CivicaRx is meeting the moment to save lives. (4/4) https://t.co/jZOaUyq4Jh
As many as one quarter of insulin users skip doses or take less than prescribed amounts due to high costs, a recent study shows.
We’re proud of Utah’s own @CivicaRx for prioritizing affordable insulin, and we are excited to see this kind of innovation in health care.
Here you can "see" the future home of @CivicaRx affordable insulin. Thanks to the many partners who are helping to make affordable insulin a reality. #affordableinsulin@washingtonpost
We @Arnold_Ventures are excited to partner with @CivicaRx to manufacture and distribute generic insulin. We will break the insulin oligopoly by bringing $30 insulin to market. Patients will no longer be the victims of America's broken drug pricing system.
https://t.co/pPBN6v6jgY